Clinical Trial Update: Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis [Phase 4]

View source ↗

Summary

An update on a Phase 4 trial comparing sorafenib monotherapy to TACE-sorafenib sequential therapy in hepatocellular carcinoma with metastasis; no results or cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Korea University | Conditions: Hepatocellular Carcinoma, Metastasis | Phase 4 | Status: UNKNOWN